<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The identification of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM) in the esophagus is necessary for the selection of patients with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (BE) for surveillance </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 108 esophageal biopsy and resection specimens, clinically diagnosed as BE, and stained them for CDX2, villin, HepPar-1, and cytokeratin (CK) 7 to investigate sensitivity for identifying IM </plain></SENT>
<SENT sid="2" pm="."><plain>H&amp;E-stained sections showed definite goblet cells in 94 cases </plain></SENT>
<SENT sid="3" pm="."><plain>CDX2 and villin were positive in <z:hpo ids='HP_0000001'>all</z:hpo> 94 cases </plain></SENT>
<SENT sid="4" pm="."><plain>Of 38 cardia- and 9 fundic-type mucosa samples associated with BE, 13 (34%) and 0 (0%) displayed CDX2 positivity and 21 (55%) and 1 (11%) displayed villin positivity, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>HepPar-1 was positive in 54 (57%) of 94 cases with IM and negative in the associated cardia- and fundic-type mucosa </plain></SENT>
<SENT sid="6" pm="."><plain>A full-thickness CK7 staining pattern was present in 90 (96%) of samples with IM and 22 (58%) and 0 (0%) of the associated cardia- and fundic-type mucosa, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>None of 20 control samples of morphologically <z:mpath ids='MPATH_458'>normal</z:mpath> gastric mucosa stained for CDX2 or villin </plain></SENT>
<SENT sid="8" pm="."><plain>CDX2 and villin are sensitive markers for early-stage IM and can supplement the histologic identification of this <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant condition</z:e> in the esophagus </plain></SENT>
</text></document>